IDEAYA Biosciences (IDYA) Other financing activities (2018 - 2026)
IDEAYA Biosciences (IDYA) reported Other financing activities of $1.2 million for Q1 2026, up 4.94% on a YoY basis from $1.1 million in Q1 2025, and up 373.56% sequentially from -$435000.0 in Q4 2025.
IDEAYA Biosciences (IDYA) Other financing activities (2018 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 9 years of Other financing activities data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 4.94% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 153.64% YoY), and the FY2025 full-year result was $1.5 million, up 3.75% from the prior year.
- Other financing activities climbed to $1.2 million in Q1 2026, from -$435000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $5.5 million in Q1 2024 to a low of -$8.0 million in Q4 2024.
- A 5-year average of $423937.5 and a median of $619000.0 in 2022 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 1392.08% in 2024, while the deepest fall reached 1482.12% in 2024.
- Tracing IDYA's Other financing activities over 5 years: stood at $1.0 million in 2022, then tumbled by 43.14% to $576000.0 in 2023, then sank by 1482.12% to -$8.0 million in 2024, then surged by 94.54% to -$435000.0 in 2025, then soared by 373.56% to $1.2 million in 2026.
- Business Quant data shows IDYA's Other financing activities at $1.2 million in Q1 2026, -$435000.0 in Q4 2025, and $384000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.19 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | -435,000.00 |
| Dec 31, 2025 | -435,000.00 |
| Sep 30, 2025 | 384,000.00 |
| Sep 30, 2025 | 384,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Mar 31, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | -7.96 Mn |
| Dec 31, 2024 | -7.96 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | 5.46 Mn |
| Mar 31, 2024 | 5.46 Mn |
| Dec 31, 2023 | 576,000.00 |
| Dec 31, 2023 | 576,000.00 |